These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 19929784)
1. Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives. Fülöp F; Szatmári I; Vámos E; Zádori D; Toldi J; Vécsei L Curr Med Chem; 2009; 16(36):4828-42. PubMed ID: 19929784 [TBL] [Abstract][Full Text] [Related]
2. Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design. Tajti J; Majlath Z; Szok D; Csati A; Toldi J; Fulop F; Vecsei L Curr Pharm Des; 2015; 21(17):2250-8. PubMed ID: 25557633 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of some 4-oxo-quinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents. Mazzoni O; Esposito G; Diurno MV; Brancaccio D; Carotenuto A; Grieco P; Novellino E; Filippelli W Arch Pharm (Weinheim); 2010 Oct; 343(10):561-9. PubMed ID: 20938950 [TBL] [Abstract][Full Text] [Related]
4. Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists. Borza I; Kolok S; Galgóczy K; Gere A; Horváth C; Farkas S; Greiner I; Domány G Bioorg Med Chem Lett; 2007 Jan; 17(2):406-9. PubMed ID: 17074483 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of New C-3 Substituted Kynurenic Acid Derivatives. Lőrinczi B; Csámpai A; Fülöp F; Szatmári I Molecules; 2020 Feb; 25(4):. PubMed ID: 32093108 [TBL] [Abstract][Full Text] [Related]
6. KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect. Lőrinczi B; Szatmári I Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769362 [TBL] [Abstract][Full Text] [Related]
7. Structure-function relationships for kynurenic acid analogues at excitatory pathways in the rat hippocampal slice. Robinson MB; Schulte MK; Freund RK; Johnson RL; Koerner JF Brain Res; 1985 Dec; 361(1-2):19-24. PubMed ID: 4084792 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological effects of some kynurenic acid analogs. Nagy K; Plangár I; Tuka B; Gellért L; Varga D; Demeter I; Farkas T; Kis Z; Marosi M; Zádori D; Klivényi P; Fülöp F; Szatmári I; Vécsei L; Toldi J Bioorg Med Chem; 2011 Dec; 19(24):7590-6. PubMed ID: 22079867 [TBL] [Abstract][Full Text] [Related]
9. Protective compounds in animal models of trigeminal activation and neurodegeneration. Vámos E Ideggyogy Sz; 2012 Jan; 65(1-2):64-70. PubMed ID: 22338849 [No Abstract] [Full Text] [Related]
10. Multifunctional Analogs of Kynurenic Acid for the Treatment of Alzheimer's Disease: Synthesis, Pharmacology, and Molecular Modeling Studies. Deora GS; Kantham S; Chan S; Dighe SN; Veliyath SK; McColl G; Parat MO; McGeary RP; Ross BP ACS Chem Neurosci; 2017 Dec; 8(12):2667-2675. PubMed ID: 28825789 [TBL] [Abstract][Full Text] [Related]
11. Thiokynurenates: a new group of antagonists of the glycine modulatory site of the NMDA receptor. Moroni F; Alesiani M; Galli A; Mori F; Pecorari R; Carlà V; Cherici G; Pellicciari R Eur J Pharmacol; 1991 Jun; 199(2):227-32. PubMed ID: 1720099 [TBL] [Abstract][Full Text] [Related]
12. The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid. Knyihar-Csillik E; Mihaly A; Krisztin-Peva B; Robotka H; Szatmari I; Fulop F; Toldi J; Csillik B; Vecsei L Neurosci Res; 2008 Aug; 61(4):429-32. PubMed ID: 18541319 [TBL] [Abstract][Full Text] [Related]
13. Kynurenic acid derivatives inhibit the binding of nerve growth factor (NGF) to the low-affinity p75 NGF receptor. Jaen JC; Laborde E; Bucsh RA; Caprathe BW; Sorenson RJ; Fergus J; Spiegel K; Marks J; Dickerson MR; Davis RE J Med Chem; 1995 Oct; 38(22):4439-45. PubMed ID: 7473570 [TBL] [Abstract][Full Text] [Related]
14. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists. Maj J; Rogóz Z; Skuza G; Kołodziejczyk K Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442 [TBL] [Abstract][Full Text] [Related]
15. Effect of 7-chloro kynurenic acid on glycine modulation of the N-methyl-D-aspartate response in guinea-pig myenteric plexus. Reggiani A; Maraia G; Ceserani R; Gaviraghi G Eur J Pharmacol; 1989 Sep; 168(1):123-7. PubMed ID: 2511031 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia. Gellért L; Fuzik J; Göblös A; Sárközi K; Marosi M; Kis Z; Farkas T; Szatmári I; Fülöp F; Vécsei L; Toldi J Eur J Pharmacol; 2011 Sep; 667(1-3):182-7. PubMed ID: 21664350 [TBL] [Abstract][Full Text] [Related]
17. Non-N-methyl-D-aspartate receptors mediating synaptic transmission in the avian cochlear nucleus: effects of kynurenic acid, dipicolinic acid and streptomycin. Jackson H; Nemeth EF; Parks TN Neuroscience; 1985 Sep; 16(1):171-9. PubMed ID: 3012407 [TBL] [Abstract][Full Text] [Related]
18. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity. Domenici MR; Marinelli S; Sagratella S Life Sci; 1996 May; 58(26):PL391-6. PubMed ID: 8691980 [TBL] [Abstract][Full Text] [Related]
19. Manipulation with kynurenines: a possible tool for treating neurodegenerative diseases? Vecsei L; Plangar I; Szalardy L Expert Rev Clin Pharmacol; 2012 Jul; 5(4):351-3. PubMed ID: 22943114 [No Abstract] [Full Text] [Related]
20. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis. Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]